- Corporate Officers - S
- Sinha Vikas
Insider Trading History of Sinha Vikas
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Sinha Vikas since 2015.
This trader's CIK number is 1337845.
At the time of last reporting, Sinha Vikas was the Officer of Verona Pharma Plc. (stock ticker symbol VRNA).
Also see all insider trading activities at Verona Pharma Plc.
Note that in the past
Sinha Vikas also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Verona Pharma Plc (VRNA) by Sinha Vikas
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2025 | VRNA | 0 | $0 | 184,328 | $1,738,187 | 204,000 | $102,680 |
2021 | VRNA | 0 | $0 | 20,240 | $18,575 | 0 | $0 |
Yearly summary of insider trading at Alexion Pharmaceuticals, Inc. (ALXN) by Sinha Vikas
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2016 | ALXN | 0 | $0 | 7,946 | $1,108,700 | 0 | $0 |
2015 | ALXN | 0 | $0 | 7,421 | $1,305,903 | 0 | $0 |
Yearly summary of insider trading at Kalaris Therapeutics, Inc. (ALVR) by Sinha Vikas
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2025 | ALVR | 0 | $0 | 1,411 | $4,733 | 0 | $0 |
2024 | ALVR | 0 | $0 | 55,748 | $40,029 | 0 | $0 |
2023 | ALVR | 0 | $0 | 31,306 | $97,292 | 0 | $0 |
2022 | ALVR | 0 | $0 | 10,493 | $85,253 | 0 | $0 |
Insider trading activities at 3 companies by Sinha Vikas:
1. Verona Pharma Plc (VRNA)
2. Alexion Pharmaceuticals, Inc. (ALXN)
3. Kalaris Therapeutics, Inc. (ALVR)
Table 1. Insider trading of Verona Pharma Plc (VRNA) by Sinha Vikas
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2025-08-01 | VRNA | Option Ex | 24,000 | .00 | 0 |
2025-08-01 | VRNA | Sale | 4,328 | 13.14 | 56,887 |
2025-05-20 | VRNA | Option Ex | 160,000 | .50 | 80,640 |
2025-05-20 | VRNA | Sale | 160,000 | 9.39 | 1,502,880 |
2025-04-29 | VRNA | Option Ex | 20,000 | 1.10 | 22,040 |
2025-04-29 | VRNA | Sale | 20,000 | 8.92 | 178,420 |
2021-05-04 | VRNA | Sale | 10,016 | .84 | 8,413 |
2021-02-01 | VRNA | Sale | 10,224 | .99 | 10,162 |
Table 2. Insider trading of Alexion Pharmaceuticals, Inc. (ALXN) by Sinha Vikas
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2016-08-08 | ALXN | Sale | 277 | 137.14 | 37,987 |
2016-02-29 | ALXN | Sale | 1,122 | 140.07 | 157,158 |
2016-02-08 | ALXN | Sale | 3,890 | 136.42 | 530,685 |
2016-02-04 | ALXN | Sale | 703 | 144.60 | 101,657 |
2016-02-05 | ALXN | Sale | 1,954 | 143.92 | 281,213 |
2015-08-04 | ALXN | Sale | 675 | 196.52 | 132,651 |
2015-03-02 | ALXN | Sale | 487 | 180.34 | 87,825 |
2015-02-10 | ALXN | Sale | 1,985 | 171.15 | 339,732 |
2015-02-09 | ALXN | Sale | 2,703 | 174.63 | 472,038 |
2015-02-03 | ALXN | Sale | 895 | 174.06 | 155,783 |
2015-02-04 | ALXN | Sale | 676 | 174.37 | 117,874 |
Table 3. Insider trading of Kalaris Therapeutics, Inc. (ALVR) by Sinha Vikas
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2025-02-21 | ALVR | Sale | 303 | 10.08 | 3,053 |
2025-01-23 | ALVR | Sale | 129 | 9.70 | 1,250 |
2025-01-10 | ALVR | Sale | 979 | .44 | 430 |
2024-11-19 | ALVR | Sale | 3,186 | .55 | 1,749 |
2024-11-05 | ALVR | Sale | 5,136 | .86 | 4,442 |
2024-10-21 | ALVR | Sale | 1,546 | .78 | 1,204 |
2024-10-22 | ALVR | Sale | 1,882 | .77 | 1,445 |
2024-10-03 | ALVR | Sale | 940 | .81 | 766 |
2024-08-05 | ALVR | Sale | 5,251 | .73 | 3,859 |
2024-07-02 | ALVR | Sale | 939 | .72 | 676 |
2024-05-17 | ALVR | Sale | 3,143 | .75 | 2,354 |
2024-05-03 | ALVR | Sale | 4,957 | .80 | 3,945 |
2024-04-19 | ALVR | Sale | 1,521 | .75 | 1,142 |
2024-04-22 | ALVR | Sale | 1,857 | .75 | 1,392 |
2024-02-20 | ALVR | Sale | 2,893 | .69 | 2,010 |
2024-02-05 | ALVR | Sale | 18,331 | .67 | 12,281 |
2024-01-23 | ALVR | Sale | 3,205 | .67 | 2,150 |
2024-01-04 | ALVR | Sale | 961 | .64 | 614 |
2023-11-17 | ALVR | Sale | 2,490 | 1.63 | 4,061 |
2023-10-19 | ALVR | Sale | 1,232 | 1.58 | 1,946 |
2023-10-20 | ALVR | Sale | 1,475 | 1.54 | 2,272 |
2023-10-03 | ALVR | Sale | 755 | 1.98 | 1,491 |
2023-08-17 | ALVR | Sale | 10,516 | 2.50 | 26,247 |
2023-07-19 | ALVR | Sale | 1,198 | 3.56 | 4,267 |
2023-07-20 | ALVR | Sale | 1,437 | 3.35 | 4,809 |
2023-07-05 | ALVR | Sale | 2,983 | 3.04 | 9,083 |
2023-04-20 | ALVR | Sale | 1,466 | 3.63 | 5,315 |
2023-04-19 | ALVR | Sale | 1,217 | 3.71 | 4,513 |
2023-01-19 | ALVR | Sale | 5,111 | 5.08 | 25,953 |
2023-01-20 | ALVR | Sale | 1,426 | 5.14 | 7,335 |
2022-10-19 | ALVR | Sale | 1,449 | 9.36 | 13,564 |
2022-07-20 | ALVR | Sale | 1,432 | 5.21 | 7,467 |
2022-04-20 | ALVR | Sale | 1,162 | 6.68 | 7,766 |
2022-01-20 | ALVR | Sale | 6,450 | 8.75 | 56,456 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Sinha Vikas
(Officer of Verona Pharma Plc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.